Physician profile

Eric L Cole

Plastic Surgery · Galveston, TX

NPI 1295786960

$1,052.45

in general payments reported to CMS, 2019-2025

8 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$603.57

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Axogen $220.20 2019-2023 Avance Nerve Graft
Integra Lifesciences Corporation $198.26 2019-2024 Integra, Integra Dermal Regeneration Template, Surgimend
Abbvie INC. $181.47 2023-2024 Botox
Sientra, INC. $131.13 2022
Polynovo North America LLC $129.52 2023
Baxter Healthcare $108.69 2019
Zimmer Biomet Holdings, INC. $75.19 2019-2024 Traumaone
Kls-Martin L.P. $7.99 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Eric L Cole

$1,052.45

in general payments reported 2019-2025

Years
2019-2024
Top company
Axogen

https://glasscript.com/doctor/884436/eric-l-cole

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.